KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
KPMG shares essential knowledge of transfer pricing practices through frequent thought leadership publications, including transfer pricing policy studies, sector-specific reports and China-related newsletters.
We have a dedicated team to serve our clients both locally and overseas.
Transfer Pricing Forum, one of BNA International's special publications, provides detailed practical guidance on technical and often highly contested transfer pricing issues.